This transcript has been edited for clarity.
This is the Medscape Psychiatry Minute. I'm Dr Peter Yellowlees.
Web-based interventions are increasingly being shown to be clinically effective in reducing depression, but are they cost-effective?
Now, a team of investigators from the University of Vechta, Germany, have assessed the cost-effectiveness of a Web-based intervention (GET.ON M.E.D.) for individuals with diabetes and comorbid depression, compared with an active control group receiving Web-based psychoeducation.
The researchers used treatment response and quality-adjusted life-years as the outcomes in a randomized controlled trial with 260 participants. They found a high probability that this Web-based intervention for individuals with diabetes and comorbid depression was cost-effective compared with the active control group.
Why is this important to clinicians? This study is yet more evidence to support the use of Web-based therapy programs as an adjunct to our usual clinical care, delineating another group of patients—depressed diabetics—where such programs are cost-effective.
As psychiatrists, our practices are changing as more clinically useful patient care tools emerge. Such programs are giving us tremendous opportunities to practice better and more patient-centered care. I encourage all colleagues to explore these innovative technologies with your patients.
Thank you for listening to this Medscape Psychiatry Minute. Do continue to enjoy your practice.
Medscape Psychiatry © 2019 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: Peter M. Yellowlees. Are Web-Based Depression Interventions Cost-Effective? - Medscape - Feb 28, 2019.